Belenos Biosciences: Dual-Targeted Antibodies for Inflammation
Chronic inflammatory diseases—such as asthma, chronic obstructive pulmonary disease (COPD), and atopic dermatitis—represent some of the most persistent, expensive, and disruptive conditions in modern healthcare. For decades, the predominant treatment model has operated around symptom suppression rather than remission, with patients tethered to inhalers, pills, topical steroids, and infusions that must be taken relentlessly to…
